Overview

A Clinical Trial of KT07 Capsule in the U.S.A

Status:
Completed
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.
Phase:
Phase 2
Details
Lead Sponsor:
Yiling Pharmaceutical Inc.